Shandong Sinobioway Biomedicine Co Ltd (002581) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.043x

Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) has a cash flow conversion efficiency ratio of -0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-86.58 Million ≈ $-12.67 Million USD) by net assets (CN¥1.99 Billion ≈ $291.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002581 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Shandong Sinobioway Biomedicine Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shandong Sinobioway Biomedicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sinobioway Biomedicine Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gopal Snacks Ltd NSE:GOPAL	0.120x
Adesso SE XETRA:ADN1	0.132x
Guilin Tourism Corp Ltd SHE:000978	0.059x
Sonmez Pamuklu Sanayii AS IS:SNPAM	0.015x
Gourmet Master Co Ltd TW:2723	0.067x
MCBC Holdings Inc NASDAQ:MCFT	0.025x
Qijing Machinery SHG:603677	0.056x
Neosem Inc KQ:253590	0.014x

Annual Cash Flow Conversion Efficiency for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 002581 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.02 Billion ≈ $295.93 Million	CN¥-6.55 Million ≈ $-958.04K	-0.003x	+80.72%
2023-12-31	CN¥2.17 Billion ≈ $318.08 Million	CN¥-36.51 Million ≈ $-5.34 Million	-0.017x	+23.91%
2022-12-31	CN¥2.47 Billion ≈ $361.21 Million	CN¥-54.49 Million ≈ $-7.97 Million	-0.022x	-18.45%
2021-12-31	CN¥2.47 Billion ≈ $361.34 Million	CN¥-46.02 Million ≈ $-6.73 Million	-0.019x	-320.54%
2020-12-31	CN¥2.19 Billion ≈ $320.56 Million	CN¥18.51 Million ≈ $2.71 Million	0.008x	-58.31%
2019-12-31	CN¥2.39 Billion ≈ $349.56 Million	CN¥48.41 Million ≈ $7.08 Million	0.020x	-23.24%
2018-12-31	CN¥2.82 Billion ≈ $412.66 Million	CN¥74.46 Million ≈ $10.90 Million	0.026x	-71.58%
2017-12-31	CN¥2.92 Billion ≈ $427.04 Million	CN¥271.11 Million ≈ $39.67 Million	0.093x	+38.67%
2016-12-31	CN¥2.53 Billion ≈ $369.84 Million	CN¥169.32 Million ≈ $24.78 Million	0.067x	+4.28%
2015-12-31	CN¥2.14 Billion ≈ $313.71 Million	CN¥137.73 Million ≈ $20.15 Million	0.064x	-39.90%
2014-12-31	CN¥749.40 Million ≈ $109.66 Million	CN¥80.11 Million ≈ $11.72 Million	0.107x	-5.07%
2013-12-31	CN¥738.31 Million ≈ $108.04 Million	CN¥83.13 Million ≈ $12.16 Million	0.113x	+25.83%
2012-12-31	CN¥704.41 Million ≈ $103.08 Million	CN¥63.04 Million ≈ $9.22 Million	0.089x	-19.17%
2011-12-31	CN¥672.28 Million ≈ $98.38 Million	CN¥74.43 Million ≈ $10.89 Million	0.111x	-77.09%
2010-12-31	CN¥177.34 Million ≈ $25.95 Million	CN¥85.71 Million ≈ $12.54 Million	0.483x	+15.97%
2009-12-31	CN¥129.71 Million ≈ $18.98 Million	CN¥54.06 Million ≈ $7.91 Million	0.417x	+3.22%
2008-12-31	CN¥116.12 Million ≈ $16.99 Million	CN¥46.89 Million ≈ $6.86 Million	0.404x	+35.21%
2007-12-31	CN¥83.94 Million ≈ $12.28 Million	CN¥25.07 Million ≈ $3.67 Million	0.299x	--

About Shandong Sinobioway Biomedicine Co Ltd

SHE:002581 China Drug Manufacturers - Specialty & Generic

Market Cap

$379.40 Million

CN¥2.59 Billion CNY

Market Cap Rank

#13822 Global

#4138 in China

Share Price

CN¥3.93

Change (1 day)

+0.00%

52-Week Range

CN¥3.53 - CN¥11.02

All Time High

CN¥39.86